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wavefronts (3), resulting in sustained ventricular tachycardia.
These two mechanisms may be important in the generation and
maintenance of sustained ventricular tachycardia near the papillary
muscle.
Clearly separated Purkinje potentials are characteristic findings
for endocardial recordings near the papillary muscle (2,3). Success-
ful radiofrequency ablation at these sites (1) suggests that the
reentrant wavefronts responsible for idiopathic left ventricular
tachycardia are adjacent to or are located within the papillary
muscle.
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REPLY
We are grateful for the opportunity to respond to the comments by
Dr. Chen et al. concerning our recent article in the Journal (1). I
was very impressed by the study of Joyner et al. (2), that reported
on longitudinal dissociation of ventricular muscle and Purkinje
signals in isolated papillary muscle of a dog. According to Figure
1B in their article, pacing from a Purkinje strand inserting into the
apex of the papillary muscle resulted in apex to base Purkinje
activation, which then excited the ventricular muscle via the
Purkinje-muscle junction at the base of the papillary muscle with
propagation of the excitation from the base to apex of the papillary
muscle. Their Figure 1B is similar to our Figure 2A, as Dr. Chen
et al. have suggested. According to the results of Joyner et al. (2),
our diastolic potential (P1) appeared to be the result of a signal
from the local ventricular muscle of the papillary muscle, and our
presystolic potential (P2) that from the local Purkinje activation of
the papillary muscle. However, there are several differences be-
tween our study and the study by Joyner et al. First, while the
Purkinje-muscle junction in their study was located at the base of
the papillary muscle, the Purkinje-muscle transmission occurred at
the infero-apical septum in our study. The position of the
octapolar electrode catheter shown in our Figure 1 differed from
the site of the posterior papillary muscle. The activation sequences
of the Purkinje potential during sinus rhythm may also differ.
Because Purkinje fibers enter the anterior and posterior papillary
muscles through the trabeculae carneae, the activation sequence of
the Purkinje potential in the papillary muscle during sinus rhythm
must be from the apex to the base. However, our P2 was recorded
earlier from the proximal than the distal electrodes during sinus
rhythm. We think that P1 is the potential from the trabeculae
carneae. Trabeculae carneae form ridges, bridges and small papil-
lary muscles. Lai et al. (3) proposed a false tendon or interlacing
Purkinje fiber as a link between the slow conduction tissue and left
posterior fascicle. Gallagher et al. (4) and Thakur et al. (5) have
also implied that the left ventricular muscular band may be the
anatomic substrate for idiopathic left ventricular tachycardia.
However, Lin et al. (6) have shown that the left ventricular
muscular band is not the specific arrhythmogenic substrate for this
tachycardia. However, trabeculae carneae or small papillary mus-
cles cannot be detected by echocardiography. Nevertheless, longi-
tudinal dissociation of the ventricular muscle and Purkinje signals
from the papillary muscle and trabeculae carneae, and the presence
of the Purkinje-muscle junction, are important in considering the
reentry circuit of verapamil-sensitive idiopathic left ventricular
tachycardia.
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The Enigma of Primary
Pulmonary Hypertension
Riley et al. (1) observed that exercise increased heart rates and
decreased oxygen saturations of arterial hemoglobin abnormally in
patients who had primary pulmonary hypertension. They stated
that this occurs in subjects with circulatory disease or decondition-
ing. They did not refer to the studies showing that fast heart rates
and desaturation of arterial hemoglobin also occur in well-trained
athletes (2,3). They did not measure cardiac outputs in their
patients to allow them to calculate stroke volumes, but they
concluded that low stroke volume, resulting from pulmonary
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hypertension, was probably the main factor responsible for the
abnormalities that they observed.
The authors showed that the patients, who had primary pulmo-
nary hypertension, worked more slowly, did less work and recov-
ered more slowly than normal subjects. Inhaling nitric oxide
reduced the patients’ pulmonary arterial pressures, but changed
none of the above abnormal measurements. This made it difficult
to claim that the pulmonary hypertension was the cause of the
abnormal measurements. The decrease of pulmonary artery pres-
sure after inhalation of nitric oxide and possible, but undemon-
strated, increase of blood flow resembled Wilson and Ferraro’s (4)
study using hydralazine. This showed that hydralazine decreased
arterial pressure and increased cardiac output during exercise in
heart failure, but did not influence exercise oxygen consumption or
peak lactate concentration or oxygen debt (4). Dilating blood
vessels, reducing intravascular pressures and increasing blood flow
did not correct the important abnormalities in either situation.
A new clue concerning pulmonary hypertension is in the report
of Driss et al. (5) of producing tiny left ventricular infarcts that did
not change left ventricular hemodynamics or size, but caused
pulmonary hypertension. Riley et al. (1) should extend their studies
into the field of neurohumoral and other signaling to improve our
understanding of primary pulmonary hypertension.
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REPLY
We thank Dr. Krohn for his thoughtful comments. The mecha-
nism for the desaturation seen in some elite athletes is likely to be
related to the high cardiac output leaving insufficient time for
equilibration of oxygen tensions between the alveolus and alveolar
capillaries. Oxyhemoglobin desaturation in response to maximal
exercise is a very unusual finding in normal adults performing
exercise near sea level (1). Cardiac output at peak exercise is low in
patients with primary pulmonary hypertension (PPH). Desatura-
tion is unlikely to be due to the same mechanism as that occurring
in elite athletes. Arterial oxyhemoglobin desaturation is not a
feature of circulatory diseases or deconditioning.
We found that nitric oxide (NO) reduced right ventricular
systolic pressure (RVSP) at rest in our patients with PPH, but
failed to alter exercise responses. Several factors may have been
responsible: 1) Nitric oxide may not have improved cardiac output,
despite causing a fall in pulmonary vascular resistance; NO may
adversely affect the positive inotropic response to beta-adrenergic
stimulation in left ventricular dysfunction (2) resulting in reduced
cardiac contractility. 2) Hemodynamic improvement present at
rest may not have been sustained during exercise; our study was
noninvasive and we could not be sure that NO improved either
RVSP or cardiac output during exercise. 3) As proposed by Dr.
Krohn, peripheral factors may have limited the benefit of any rise
in cardiac output with NO. In patients with chronic left ventricular
failure, Wilson et al. (3,4) found an increase in cardiac output with
the acute administration of hydralazine or isosorbide dinitrate
during submaximal exercise or dobutamine during maximal exer-
cise. However, none of these drugs improved total oxygen con-
sumption, oxygen uptake across the exercising leg or venous
lactate. This paradox was attributed to a failure of “nutritive” flow
to increase in the exercising muscle. Even though peripheral
oxygen extraction is high in patients with PPH (5), it is possible
that the peripheral circulation may not have been able to distribute
appropriately any additional acute increase in cardiac output caused
by NO inhalation.
We agree that the study of neurohumoral mechanisms in PPH
may prove fruitful. Endothelin is known to be elevated in patients
with PPH (6) and may be important in promoting vascular
remodeling. At present it is unclear whether abnormalities of other
vasoactive hormones also occur. However, even if neurohumoral
abnormalities occur under conditions of circulatory stress, the
matter of discerning cause and effect will remain.
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